Kai-Ping Chang ,MD, PhD.
Institution: Chang Gung Memorial Hospital & College of Medicine, Chang Gung University
Position:
Professor
Department: Department of Otolaryngology-Head and Neck Surgery
Office Address: No.5, Fusing St., Gueishan Township, Taoyuan County 333, Taiwan 
Tel: +886-3-3281200 ext.3968 Fax: +886-3-3979361
E-mail: kpchang@cgmh.org.tw 
Focus of Interest:- Oncology
- Dentistry, Oral Surgery & Medicine
- Otolaryngology
Employment Records:
June 28,1998 ～ June 30, 2002
Residency: Department of Otolaryngology-Head and Neck Surgery
Chang Gung Memorial Hospital
Education:
MD Degree, School of Medicine,Chang Gung University, Kwei-Shan, Tao-Yuan, Taiwan, ROC. 1989-1996.
PhD Degree, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Kwei-Shan, Tao-Yuan, Taiwan, ROC.2003-2008.
Board Certification / Professional Affiliations:
Taiwan Physician Board, September 16, 1996
ECFMG Certificate (Educational Commission for Foreign Medical Graduate, U.S.A.)March 4, 1998
Taiwan Otolaryngologist Board, Jun 30, 2002
The Clinical Oncology Board of the Taiwan Clinical Oncology Society, Sep 2, 2005
Selected Publications:
1. Chang KP, Hao SP, Chang JH, Wu CC, Tsang NM, Lee YS, Hsu CL, Ueng SH, Liau SC, Liu YL, Wei PC, Liang Y, Chang YS, Yu JS*. Macrophage Inflammatory Protein-3α Is a Novel Serum Marker for Nasopharyngeal Carcinoma Detection and Prediction of Treatment Outcomes. Clin Cancer Res. 2008; 14(21): 6979-6987.
2.
Chang KP, Wu CC, Chen HC, Chen SJ, Peng PH, Tsang NM, Lee LY, Liu SC, Liang Y, Lee YS, Hao SP, Chang YS, Yu JS*. Identification of Candidate Nasopharyngeal Carcinoma Serum Biomarkers by Cancer Cell Secretome and Tissue Transcriptome Analysis: Potential Usage of Cystatin A for Predicting Nodal Stage and Poor Prognosis. Proteomics. 2010; 10: 2644-2660.
3. Chang KP, Yu JS, Chien KY, Lee CW, Liang Y, Liao CT, Yen TC, Lee LY, Huang LL, Liu SC, Chang YS, Chi LM*. Identification of PRDX4 and P4HA2 as metastasis-associated proteins in oral cavity squamous cell carcinoma by comparative tissue proteomics of microdissected specimens using iTRAQ technology. J Proteome Res. 2011; 10(11):4935-47.
4. Chang KP*, Tsang NM, Liao CT, Hsu CL, Chang MJ, Lo CW, Chang SC, Ng SH, Wang HM, Yen TC. Prognostic significant of 18F-FDG PET parameters and plasma EBV DNA load in patients with nasopharyngeal carcinoma. J Nucl Med. 2012; 53(1): 21-28.
5. Chang KP, Wang CA, Kao HK, Ying L, Liu SC, Huang LL, Hseuh C, Hsieh YJ, Chien KY, Chang YS, Yu JS, Chi LM*. Overexpression of caldesmon is associated with nodal metastasis and poorer prognosis in oral cavity squamous cell carcinomas. Cancer. 2013; 119: 4003-11.
Full Publication List
Honor and Awards:
2008 AAOHNS Honor Award
Ongoing Projects：
2014/01 ～ 2016/12 EBV-NPC program: Biomarkers discovery for translational applications.(Sp1)Searching for genomic and proteomic markers for NPC susceptiblity and screening program. (Chief Principal Investigator and Principal Investigator of SP1)
2014/01～2016/12 Application of point spectroscopy and high-resolution microendoscope in OSCC screening and post-treated monitoring.
2013/08 ～ 2016/07 (Principal Investigator)
Searching the detection and metastasis biomarkers in the body fluids and tissues from patients with oral cavity cancers based on the secretomic and tissue proteomic databases.